Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects

Journal of Virology

Volumn 85, Issue 21, 2011, Pages 11526-11531

  Tandon, Ravi ^a   SenGupta, Devi ^a   Ndhlovu, Lishomwa C ^a,d   Vieira, Raphaella G S ^a   Jones, R Brad ^c   York, Vanessa A ^a   Vieira, Vinicius A ^a   Sharp, Elizabeth R ^a   Wiznia, Andrew A ^b   Ostrowski, Mario A ^c   Rosenberg, Michael G ^b   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GAMMA INTERFERON; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADOLESCENT; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; CRYOPRESERVATION; ENDOGENOUS RETROVIRUS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; NOTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; VERTICAL TRANSMISSION; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; ENDOGENOUS RETROVIRUSES; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PLASMA; T-LYMPHOCYTES; VIRAL LOAD;

HUMAN ENDOGENOUS RETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80055112237     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05418-11     Document Type: Note

References (27)

1. An, D. S., Y. Xie, and I. S. Chen. 2001. Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope. J. Virol. 75:88-3489.
2. Barbulescu, M., et al. 1999. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr. Biol. 9:861-868.
3. Benit, L., J. B. Lallemand, J. F. Casella, H. Philippe, and T. Heidmann. 1999. ERV-L elements: a family of endogenous retrovirus-like elements active throughout the evolution of mammals. J. Virol. 73:01-3308.
4. Boller, K., et al. 1993. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 196:9-353.
5. Connor, E. M., et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1173-1180.
6. Contreras-Galindo, R., M. H. Kaplan, D. M. Markovitz, E. Lorenzo, and Y. Yamamura. 2006. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses 22:979-984.
7. Contreras-Galindo, R., P. Lopez, R. Velez, and Y. Yamamura. 2007. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res. Hum. Retroviruses 23:6-122.
8. de Parseval, N., J. Casella, L. Gressin, and T. Heidmann. 2001. Characterization of the three HERV-H proviruses with an open envelope reading frame encompassing the immunosuppressive domain and evolutionary history in primates. Virology 279:8-569.
9. di Maria, H., et al. 1986. Transplacental transmission of human immunodeficiency virus. Lancet ii:5-216.
10. Garrison, K. E., et al. 2007. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog. 3:e165.
11. Laderoute, M. P., et al. 2007. The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia. AIDS 21:2417-2424.
12. Lewis, S. H., C. Reynolds-Kohler, H. E. Fox, and J. A. Nelson. 1990. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 335:5-568.
13. Lower, R., et al. 1993. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc. Natl. Acad. Sci. U. S. A. 90:80-4484.
14. Magder, L. S., et al. 2005. Risk factors for in utero and intrapartum transmission of HIV. J. Acquir. Immune Defic. Syndr. 38:87-95.
15. Mayer, J., et al. 2004. Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity. Virology 322:190-198.
16. Mayer, J., E. Meese, and N. Mueller-Lantzsch. 1997. Chromosomal assignment of human endogenous retrovirus K (HERV-K) env open reading frames. Cytogenet. Cell Genet. 79:7-161.
17. McCune, J. M. 1991. HIV-1: the infective process in vivo. Cell 64:1-363.
18. McIntosh, K., et al. 1996. Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus. Pediatr. Infect. Dis. J. 15:87-1091.
19. Mofenson, L. M., et al. 1997. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. J. Infect. Dis. 175: 29-1038.
20. Nelson, P. N. 1995. Retroviruses in rheumatic diseases. Ann. Rheum. Dis. 54:1-442.
21. Nelson, P. N., et al. 1999. Molecular investigations implicate human endog-enous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease. Immunol. Invest. 28:7-289.
22. Rich, K. C., et al. 2000. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Pediatrics 105:e8.
23. SenGupta, D., et al. 2011. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J. Virol. 85:6977-6985.
24. Sharp, E. R., et al. 2005. Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1. J. Infect. Dis. 192:1772-1780.
25. Sprecher, S., G. Soumenkoff, F. Puissant, and M. Degueldre. 1986. Vertical transmission of HIV in 15-week fetus. Lancet ii:288-289.
26. Sugimoto, J., and D. J. Schust. 2009. Review: human endogenous retroviruses and the placenta. Reprod. Sci. 16:23-1033.
27. Wade, N. A., et al. 2004. Decline in perinatal HIV transmission in New York State (1997-2000). J. Acquir. Immune Defic. Syndr. 36:1075-1082.